6 days ago
SRRK
AnalystsTessa RomeroTessa Romero's Stock Forecasts
AnalystsTessa Romero
Sectors:
Industries:
Analyst Ranking
Top 11%
#592 out of 5496 analysts
Average Return
+20.57%
Win Rate
55%43 out of 78
Risk vs Reward
Poor
Good
Tessa Romero's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Scholar Rock Holding CorpSRRK | +397.74% | $7.07 | $35.19 | 2024-10-03 - 2025-10-02 | Strong Buy |
Dyne Therapeutics IncDYN | +307.09% | $10.58 | $43.07 | 2023-08-09 - 2024-08-08 | Strong Buy |
Edgewise Therapeutics IncEWTX | +219.64% | $13.80 | $44.11 | 2025-08-19 - 2026-08-18 | Strong Buy |
Biohaven LtdBHVN | +174.33% | $14.65 | $40.19 | 2023-01-04 - 2024-01-03 | Strong Buy |
Edgewise Therapeutics IncEWTX | +132.39% | $7.75 | $18.01 | 2023-06-30 - 2024-06-28 | Strong Buy |
Tessa Romero Analyst Color
Get additional color on Tessa Romero's coverage of popular stocks
6 days ago
CYTK
3 months ago
OCS
5 months ago
EWTX
5 months ago
SRRK
6 months ago
ACAD
7 months ago
XENE
9 months ago
XENE
9 months ago
SRRK
9 months ago
EWTX
2 years ago
BHVN
2 years ago
CYTK
2 years ago
BHVN
Tessa Romero's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eyepoint IncEYPT | 4 | Hold | N/A | N/A | Downgrades | 2 days ago |
Oculis Holding AgOCS | 4 | Strong Buy | $20.00 | +51.63% | Maintains | 5 days ago |
Upstream Bio IncUPB | 3 | Hold | $9.00 | +31.39% | Maintains | 5 days ago |
Scholar Rock Holding CorpSRRK | 7 | Strong Buy | $63.00 | +15.13% | Maintains | 6 days ago |
Cytokinetics IncCYTK | 9 | Strong Buy | $103.00 | +35.35% | Maintains | 6 days ago |
Agios Pharmaceuticals IncAGIO | 11 | Hold | $34.00 | -1.16% | Maintains | 12 days ago |
Lexeo Therapeutics IncLXEO | 3 | Strong Buy | $9.00 | +82.56% | Maintains | 2 months ago |
Xenon Pharmaceuticals IncXENE | 6 | Strong Buy | $82.00 | +29.79% | Maintains | 3 months ago |
Larimar Therapeutics IncLRMR | 1 | Strong Buy | $9.00 | +121.67% | Initiates Coverage On | 3 months ago |
Seaport Therapeutics IncSPTX | 1 | Strong Buy | $42.00 | +75.22% | Initiates Coverage On | 3 months ago |
Septerna IncSEPN | 1 | Strong Buy | $38.00 | -13.24% | Maintains | 5 months ago |
Edgewise Therapeutics IncEWTX | 11 | Strong Buy | $45.00 | +2.02% | Maintains | 5 months ago |
Acadia Pharmaceuticals IncACAD | 12 | Strong Buy | $34.00 | +12.66% | Maintains | 6 months ago |
Dyne Therapeutics IncDYN | 8 | Hold | $16.00 | -38.46% | Maintains | 7 months ago |
Biohaven LtdBHVN | 8 | Strong Buy | $15.00 | +10.54% | Maintains | 9 months ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Sell | $263.00 | +7,774.25% | Downgrades | 9 months ago |
Neumora Therapeutics IncNMRA | 5 | Strong Sell | N/A | N/A | Downgrades | a year ago |
Seres Therapeutics IncMCRB | 2 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Y Mabs Therapeutics IncYMAB | 5 | Strong Sell | $7.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | $36.00 | N/A | Maintains | 4 years ago |
Orchard Therapeutics PLCORTX | 1 | Strong Buy | $150.00 | N/A | Assumes | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.